Exposure-Response Analysis of Etrolizumab in Patients with Moderately-to-severely Active Ulcerative Colitis

Pharmacometrics

Gastroenterology

ACoP12 (Nov 2021) PMX-82.

Kassir N, Zhu R, Moein A, Langenhorst J, Ribbing J, Zhang R, Tang M, Oh YS, Zhang W

External authors

Zhu R,

Kassir N,

Moein A,

Zhang R,

Tang M,

Oh YS,

Zhang W

Pharmetheus collaborators

Jakob Ribbing